Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.97
-0.38 (-2.65%)
At close: Mar 5, 2026, 4:00 PM EST
14.02
+0.05 (0.36%)
After-hours: Mar 5, 2026, 4:11 PM EST
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 53.6, with a low estimate of 12 and a high estimate of 100. The average target predicts an increase of 283.68% from the current stock price of 13.97.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Janux Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 6 | 5 | 5 | 5 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 2 | 2 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $150 → $100 | Buy | Maintains | $150 → $100 | +615.82% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $68 | Strong Buy | Maintains | $72 → $68 | +386.76% | Feb 27, 2026 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $32 → $12 | Strong Buy → Hold | Downgrades | $32 → $12 | -14.10% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +114.75% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +107.59% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
1.43M
from 10.00M
Decreased by -85.66%
Revenue Next Year
4.44M
from 1.43M
Increased by 209.90%
EPS This Year
-2.75
from -1.83
EPS Next Year
-3.33
from -2.75
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.9M | 35.3M | |||
| Avg | 1.4M | 4.4M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -21.3% | 2,362.8% | |||
| Avg | -85.7% | 209.9% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.91 | -1.73 | |||
| Avg | -2.75 | -3.33 | |||
| Low | -3.58 | -5.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.